Wuthrich B, 2003, The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE‐associated (“extrinsic”) and the nonallergic (“intrinsic”) AEDS, J Investig Allergol Clin Immunol, 13, 1
10.1111/j.1398-9995.2011.02577.x
10.1111/j.1398-9995.2012.02874.x
10.1111/j.1468-3083.2012.04636.x
10.1111/j.1468-3083.2012.04635.x
Werfel T, 2009, Atopic dermatitis: S2 guidelines, J Dtsch Dermatol Ges, 7, S1
10.1111/j.1468-3083.2009.03415.x
10.1016/S0091-6749(98)70212-X
10.1111/j.1365-2222.2006.02448.x
10.1164/rccm.200701-036OC
10.1111/j.1365-2133.2004.05710.x
10.1016/j.jaci.2016.01.015
10.1016/j.jaad.2016.07.017
10.1007/s40629-014-0022-4
10.1016/j.jaci.2016.06.010
10.1111/j.1398-9995.2004.00556.x
10.2332/allergolint.10-RAI-0273
10.1016/S0140-6736(96)91556-1
10.1046/j.1365-2133.2000.03666.x
Nankervis H, 2015, House dust mite reduction and avoidance measures for treating eczema, Cochrane Database Syst Rev, 1, CD008426
10.1111/j.0022-202X.2005.23625.x
10.1016/j.jaci.2015.04.015
10.1016/j.jaci.2013.04.009
10.1111/j.1398-9995.2010.02464.x
10.1111/j.1365-2222.2010.03566.x
10.1016/j.envres.2015.02.003
10.1007/s00105-010-2019-3
10.1097/01.all.0000136758.66442.28
10.1371/journal.pmed.1002280
10.1007/978-3-662-07677-4_1
10.1111/j.1365-2133.2012.10852.x
10.3109/09546634.2015.1067669
Ludwig G, 1968, On the topical effect of sea water tub‐baths with and without addition of an oil emulsion, Z Haut Geschlechtskr, 43, 683
10.1016/j.iac.2010.06.005
10.1080/000155502753600885
10.1111/j.1525-1470.2009.00911.x
10.1111/j.1398-9995.2007.01527.x
10.1111/j.1365-4632.2010.04551.x
10.1016/j.jaci.2003.07.001
10.1111/j.1365-2133.2008.08836.x
Mahe YF, 2013, A new Vitreoscilla filiformis extract grown on spa water‐enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll‐like receptor 2/protein kinase C, zeta transduction pathway, Clin Cosmet Investig Dermatol, 6, 191
Miller DW, 2011, An over‐the‐counter moisturizer is as clinically effective as, and more cost‐effective than, prescription barrier creams in the treatment of children with mild‐to‐moderate atopic dermatitis: a randomized, controlled trial, J Drugs Dermatol, 10, 531
10.1016/j.jaci.2014.08.005
10.1016/j.jaci.2014.07.060
10.1111/j.1399-3038.2007.00706.x
10.1111/j.1468-3083.2007.02351.x
10.1016/S0091-6749(99)70053-9
10.1111/j.1398-9995.2004.00493.x
10.1016/S0091-6749(99)70395-7
10.1111/j.1365-2222.2004.1953.x
10.1016/S0738-081X(02)00363-2
10.1111/j.1398-9995.2007.01429.x
10.1034/j.1398-9995.2000.00464.x
10.1111/j.1398-9995.2006.01136.x
10.1034/j.1399-3038.2001.121408.x
10.1046/j.1365-2230.2000.00695.x
10.1111/j.1398-9995.2004.00466.x
10.1111/j.1398-9995.2008.01917.x
10.1016/j.jaad.2003.08.003
10.1016/j.jaci.2012.02.043
10.1046/j.1365-2222.2000.00943.x
10.1111/j.1365-2133.2006.07558.x
10.1016/j.jaci.2015.04.031
10.1016/j.jaad.2016.04.060
10.1016/j.jaad.2014.01.898
10.1111/j.1610-0387.2008.06772_supp.x
10.1111/j.1398-9995.2008.01803.x
10.1046/j.1365-2133.2002.05006.x
10.1136/bmj.326.7403.1367
10.1046/j.1365-2133.1999.02893.x
10.1111/j.1365-2133.2008.08436.x
10.1016/S0190-9622(08)82011-7
10.1111/j.1525-1470.1984.tb01124.x
10.1016/S0738-081X(02)00368-1
10.1016/j.jaad.2010.01.035
10.1007/s40264-015-0287-7
Chi CC, 2015, Safety of topical corticosteroids in pregnancy, Cochrane Database Syst Rev, CD007346
10.3109/09546634.2010.534127
10.1016/j.jaad.2014.11.024
10.1111/j.1365-2133.2011.10449.x
10.3109/09546630903410158
10.1056/NEJM199709183371203
10.1001/archderm.134.7.805
10.1001/archderm.136.8.999
10.1111/j.1398-9995.2008.01683.x
10.1111/j.1365-2133.2008.08813.x
Cury Martins J, 2015, Topical tacrolimus for atopic dermatitis, Cochrane Database Syst Rev, CD009864
10.3109/09546630903401470
10.1001/archderm.139.9.1184
10.1111/j.1365-4632.2009.03853.x
10.1111/j.1365-2133.2008.08747.x
10.1111/j.1365-2133.2008.08807.x
10.1111/j.1468-3083.2010.03577.x
10.1111/j.1365-2133.2010.10141.x
10.3109/09546630903493329
Bornhövd EC, 2002, Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases, Curr Opin Investig Drugs, 3, 708
Wetzel S, 2004, Eczema molluscatum in tacrolimus treated atopic dermatitis, Eur J Dermatol, 14, 73
10.2165/00128071-200304090-00006
10.1111/j.1365-2133.2005.06592.x
10.1046/j.1523-1747.1998.00323.x
10.1046/j.1365-2133.2001.04076.x
10.1016/j.jaad.2015.02.1116
10.1111/j.1468-3083.2005.01315.x
10.1016/j.clindermatol.2009.04.001
10.1001/jamadermatol.2014.4305
Deleuran M, 2016, Topical calcineurin inhibitors, topical glucocorticoids and cancer in children: a nationwide study, Acta Derm Venereol, 96, 834
10.1016/j.jaad.2016.05.046
Stein Gold LF, 2015, A phase 2, randomized, controlled, dose‐ranging study evaluating crisaborole topical ointment, 0.5% and 2% in adolescents with mild to moderate atopic dermatitis, J Drugs Dermatol, 14, 1394
10.1016/j.jaad.2016.04.001
10.3109/09546634.2016.1157257
Patrizi A, 2009, The effect of summer holidays and sun exposure on atopic dermatitis, G Ital Dermatol Venereol, 144, 463
10.1111/j.1365-2133.2008.08498.x
10.3402/ijch.v67i2-3.18282
10.1111/j.1365-2133.2008.08518.x
10.1016/S0076-6879(00)19031-7
10.1111/1523-1747.ep12363402
10.1111/1523-1747.ep12613446
10.1046/j.1365-4362.2000.00840.x
Vocks E, 1994, Climatotherapy in atopic dermatitis, Allergologie, 17, 208
Larko O, 1982, Is UVB treatment of psoriasis safe? A study of extensively UVB‐treated psoriasis patients compared with a matched control group, Acta Derm Venereol, 62, 507, 10.2340/0001555562507512
10.1080/00015550410026948
10.1371/journal.pone.0020566
Mavilia L, 2008, 308 nm monochromatic excimer light in dermatology: personal experience and review of the literature, G Ital Dermatol Venereol, 143, 329
10.1007/s00105-009-1828-8
10.1111/j.1365-2230.2007.02644.x
10.1111/j.1365-2133.1987.tb04091.x
10.1016/S0190-9622(83)70131-3
10.1016/S0190-9622(99)70249-5
10.1111/j.1365-2230.2008.02906.x
10.1111/j.1365-2133.2008.08984.x
10.3109/09546630903341986
10.1111/j.1468-3083.2012.04578.x
Herzog JL, 2011, A randomized, double‐blind, vehicle‐controlled crossover study to determine the anti‐pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long‐acting opiod antagonist nalmefene in subjects with atopic dermatitis, J Drugs Dermatol, 10, 853
Hauss H, 1993, Vergleichende untersuchungen zu behandlung von trockener, juckender haut mit einer zubreitung aus harnstoff und polidocanol sowie mit einer linolsäure‐haltigen fettcreme. Ergebnisse aus der praxis, Derm Beruf Umwelt, 41, 184
10.1111/j.1398-9995.1998.tb03867.x
10.1111/j.1398-9995.1994.tb00768.x
La Rosa M, 1994, Double‐blind study of cetirizine in atopic eczema in children, Ann Allergy, 73, 117
10.1111/j.1365-2133.1990.tb14732.x
Hannuksela M, 1993, Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults, Ann Allergy, 70, 127
Chunharas A, 2002, Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream, J Med Assoc Thai, 85, 482
10.1016/j.jdermsci.2006.04.002
10.1046/j.1365-2133.2003.05293.x
10.1111/j.1399-3038.2007.00558.x
10.1016/S0091-6749(99)70389-1
10.1016/S0190-9622(89)80353-6
10.1111/j.1365-2230.1988.tb00744.x
10.1016/0091-6749(88)90571-4
10.1016/S0190-9622(99)70292-6
10.1111/j.1468-3083.2009.03129.x
